Skip to main content
. 2020 Sep 15;9(22):8444–8456. doi: 10.1002/cam4.3466

Figure 1.

Figure 1

ESTIMATE, stroma, and immune scores in TCGA‐SKCM of melanoma patients by ESTIMATE algorithm analysis. (A–D): ESTIMATE, stroma, and immune scores and tumor purity, respectively, at different stages. The lowest ESTIMATE, stroma, and immune scores were in stage II. (E–H): Association between survival curves and different ESTIMATE, stroma, and immune scores and tumor purity, respectively, in melanoma patients in TCGA‐SKCM. (n = 471, * P < .05, *** P < .001, and **** P < .0001)